Filter Results :

Your search for Pharmaceutical returned 23867 reports

Sort by


Nigeria Pharmaceuticals and Healthcare Report

22 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Nigeria's pharmaceutical market will continue to be viewed as a high-risk proposition for multinational pharmaceutical companies. Rampant corruption, coupled with widespread drug counterfeiting and poor pharmaceutical regulations governing the market will not bode well for investor s...

$ 1,295.00

Read More

Colombia Pharmaceuticals and Healthcare Report

22 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Colombia's deteriorating regulatory regime will continue to limit the country's attractiveness to multinational pharmaceutical companies in the coming years. Despite the country's growing rates of medicine consumption, the increasing compulsory license risks and patent regulation bur...

$ 1,295.00

Read More

Healthcare BPO Market by Provider (Billing), Payer (Claims Management), Pharmaceutical (R&D, Non-Clinical (SCM, Sales and Marketing (Forecasting, Analytics))), Outsourcing Approaches (Bundled), & Models (Multisourcing, Captives) - Global Forecasts to 2021

22 Jun 2016  |  Published by:  MarketsandMarkets
Healthcare BPO Market - Provider (Billing), Payer (Claims management), Pharmaceutical (R&D, Non-Clinical (SCM, Sales and Marketing (Forecasting, Analytics))), Outsourcing Approaches (Bundled) & Models (Multisourcing, Captives) - Global Forecasts to 2021 Focus on Reduction of Healthc...

$ 5,650.00

Read More

Pharmathen Pharmaceuticals S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

18 Jun 2016  |  Published by:  GlobalData
SummaryPharmathen Pharmaceuticals S.A (Pharmathen) is a pharmaceutical company that develops and markets generic products. The company’s products include retinoid, serotonin and noradrenaline re-uptake inhibitor, beta1-selective adrenergic receptor blocking agent, anti-hypertensive a...

$ 250.00

Read More

Global and China Active Pharmaceutical Ingredients Research Report to 2020

16 Jun 2016  |  Published by:  QYResearch
This report studies Active Pharmaceutical Ingredients in Global and China market, focuses on price, sales, revenue of each type in global China. This report also focuses on the sales (consumption), production, import and export of Active Pharmaceutical Ingredients in USA, Japan, Italy, India, Other ...

$ 2,500.00

Read More

Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, Lubricant, Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021

16 Jun 2016  |  Published by:  MarketsandMarkets
The global pharmaceutical excipients market is projected to grow at a strong CAGR of 6.1% during the forecast period of 2016-2021 to reach USD 8.1 billion by 2021. The market is mainly driven by emergence of new excipients for the pharmaceutical industry, growing generic drugs market, developm...

$ 5,650.00

Read More

Portugal Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Portugal's expansionary budget will continue to support rising domestic consumption indices,which will contribute to modest pharmaceutical market growth rates over a multi-quarter horizon.However, the government will do little to continue structural reform aimed at boosting competitiveness...

$ 1,295.00

Read More

Singapore Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Prospects for Singapore's healthcare sector will be robust. Supported by the government's consistent investments into the sector, the country has developed a strong research foundation which will inturn serve to augment Singapore's competitive edge in clinical trials and medical tourism. A...

$ 1,295.00

Read More

Thailand Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Thailand's private healthcare providers will be well positioned for growth. Supporting thistrajectory is the country's popularity as a medical tourism destination, augmenting domestic demand formedical services. Private hospitals also have the opportunity to expand into frontier markets in...

$ 1,295.00

Read More

Saudi Arabia Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Over the forthcoming years, growth in Saudi Arabia's pharmaceutical and healthcare marketswill remain elevated. The government's ongoing commitment to sector development will continue to attract investments from multinational drug makers and healthcare companies. More recently, the Kingdom...

$ 1,295.00

Read More

Chile Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Chile's government will continue to increase its investment in healthcare and play anincreasingly important role in providing greater healthcare coverage to local citizens. This will offer considerable commercial opportunities for pharmaceutical companies and healthcare providers. Generic ...

$ 1,295.00

Read More

Romania Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: In line with Romania's economic out performance in Europe, the country's pharmaceutical and healthcare markets will see strong growth given increased consumer spending power and higher healthcare contributions. However, aggressive drug pricing regulations, including the imminent joint drug...

$ 1,295.00

Read More

Russia Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Russia's healthcare market is in a precarious position due to a severe lack of funding and anescalating burden of disease. The country's economic recession will see further pressure placed on thepopulation for provision of care. Amendments to Russia's pharmaceutical legislation will, howev...

$ 1,295.00

Read More

Spain Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Growth in the Spanish pharmaceutical market will remain slow but steady, despite being aneconomic outperformer in Western Europe. The ageing population of Spain, and the wider Europe region,will create significant revenue earning opportunities for drugmakers. However, as populations age, t...

$ 1,295.00

Read More

Panama Pharmaceuticals and Healthcare Report

15 Jun 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The local government's increasing investment in the public healthcare system will significantlyimprove the population's access to medicines and provide revenue-generating opportunities for pharmaceutical companies. The business-friendly environment and Colón Free Trade Zone will also boost...

$ 1,295.00

Read More
Total 23867 records.